TABLE 3.
Detection of betanodavirus RNA2 in infected fisha
| Trial | Vaccine | Treatment or VLP dose (μg · fish−1) | No. of fish with VNN clinical signs positive by RT-PCR/no. of fish examined | No. of dead fish positive by RT-PCR/no. of fish examined | No. of asymptomatic fish positive by RT-PCR/no. of fish examined |
|---|---|---|---|---|---|
| 1 | MGNNV VLPs | 20 | NDb | 12/44 | |
| 100 | 1/1 | 2/54 | |||
| Unvaccinated | 3/3 | 1/4 | 1/5 | ||
| 2 | SB2 VLPs | 0.1 | 3/3 | 14/14 | 14/15 |
| 0.5 | 1/1 | 18/18 | 15/15 | ||
| 1 | 2/2 | 9/9 | 14/15 | ||
| 5 | 4/4 | 14/15 | |||
| 10 | 4/4 | 11/15 | |||
| 20 | 1/1 | 3/3 | 6/15 | ||
| Unvaccinated | 9/9 | 17/17 | 17/17 |
RT-PCR analysis was performed using RNA extracted from the eyes and brains of challenged fish as described in Materials and Methods.
ND, not determined.